Reduced diagnostic accuracy of screening questionnaires in older psychiatric patients at risk for obstructive sleep apnea: an observational cohort study.
Sleep & breathing = Schlaf & Atmung · 2026
Abstract originale
BACKGROUND: Obstructive sleep apnea (OSA) is highly prevalent among geriatric patients and is associated with increased mortality, reduced quality of life, depression, and cognitive decline. Early identification and treatment are particularly important in older psychiatric patients, in whom typical OSA symptoms overlap with psychiatric and aging-related symptoms. Screening questionnaires are used to identify patients at risk for OSA, but their performance in older psychiatric populations is largely unknown. This study compared the diagnostic accuracy of screening questionnaires between younger and older psychiatric inpatients at risk for OSA and assessed the discriminative value of chronological age alone. PATIENTS AND METHODS: Observational study of consecutive admissions to a psychiatric ward at University Hospital Erlangen (June 2016-December 2022). 128 screened patients at risk for OSA with valid overnight polygraphy and questionnaire data were analyzed (72 aged 18-64 years; 56 aged ≥ 65 years). Risk scores were calculated for STOP-Bang, STOP-B28, BOAH, GOAL, NoSAS and No-Apnea questionnaires. The reference standard was apnea-hypopnea-index (AHI) measured by polygraphy. Primary outcome measures were the area under the receiver operating characteristic curve (AUC), sensitivity and specificity for any OSA (AHI ≥ 5 events/h). The discriminative value of age and individual questionnaire components was evaluated in the entire cohort. RESULTS: In the screened cohort of psychiatric inpatients, older patients had higher median AHI (7.7 vs. 1.8 events/h; p = 0.007), greater prevalence of any OSA (AHI ≥ 5: 73.2% vs. 47.2%; p = 0.003), deeper desaturations and longer apneas. In younger patients, questionnaire AUCs ranged 0.61-0.78. In the older subgroup, AUCs were 0.12-0.36 lower; BOAH had the highest AUC (0.59), while the other questionnaires showed AUCs of 0.38-0.49. The lower discrimination was mainly reflected in lower specificity. Chronological age yielded an AUC of 0.70 (95% CI, 0.61-0.80), whereas BMI, neck circumference, and symptom-based items showed poor discrimination. CONCLUSIONS: In our sample of psychiatric inpatients at risk for OSA, commonly used screening questionnaires demonstrated markedly reduced diagnostic performance in patients aged ≥ 65 years, largely reflecting lower specificity. Chronological age demonstrated moderate discriminative value. Further research is warranted regarding the accuracy of OSA screening in older patients, and a lower threshold for device-based diagnostics may warrant consideration.
Parole chiave
Leggi il testo integrale originale
Testo estratto dalla pubblicazione: sono esclusi immagini, media, supplementi e parti soggette a diritti distinti.
Reduced diagnostic accuracy of screening questionnaires in older psychiatric patients at risk for obstructive sleep apnea: an observational cohort study
Background
Obstructive sleep apnea (OSA) is highly prevalent among geriatric patients and is associated with increased mortality, reduced quality of life, depression, and cognitive decline. Early identification and treatment are particularly important in older psychiatric patients, in whom typical OSA symptoms overlap with psychiatric and aging-related symptoms. Screening questionnaires are used to identify patients at risk for OSA, but their performance in older psychiatric populations is largely unknown. This study compared the diagnostic accuracy of screening questionnaires between younger and older psychiatric inpatients at risk for OSA and assessed the discriminative value of chronological age alone.
Patients and methods
Observational study of consecutive admissions to a psychiatric ward at University Hospital Erlangen (June 2016–December 2022). 128 screened patients at risk for OSA with valid overnight polygraphy and questionnaire data were analyzed (72 aged 18–64 years; 56 aged ≥ 65 years). Risk scores were calculated for STOP-Bang, STOP-B28, BOAH, GOAL, NoSAS and No-Apnea questionnaires. The reference standard was apnea-hypopnea-index (AHI) measured by polygraphy. Primary outcome measures were the area under the receiver operating characteristic curve (AUC), sensitivity and specificity for any OSA (AHI ≥ 5 events/h). The discriminative value of age and individual questionnaire components was evaluated in the entire cohort.
Results
In the screened cohort of psychiatric inpatients, older patients had higher median AHI (7.7 vs. 1.8 events/h; p = 0.007), greater prevalence of any OSA (AHI ≥ 5: 73.2% vs. 47.2%; p = 0.003), deeper desaturations and longer apneas. In younger patients, questionnaire AUCs ranged 0.61–0.78. In the older subgroup, AUCs were 0.12–0.36 lower; BOAH had the highest AUC (0.59), while the other questionnaires showed AUCs of 0.38–0.49. The lower discrimination was mainly reflected in lower specificity. Chronological age yielded an AUC of 0.70 (95% CI, 0.61–0.80), whereas BMI, neck circumference, and symptom-based items showed poor discrimination.
Conclusions
In our sample of psychiatric inpatients at risk for OSA, commonly used screening questionnaires demonstrated markedly reduced diagnostic performance in patients aged ≥ 65 years, largely reflecting lower specificity. Chronological age demonstrated moderate discriminative value. Further research is warranted regarding the accuracy of OSA screening in older patients, and a lower threshold for device-based diagnostics may warrant consideration.
Supplementary Information
The online version contains supplementary material available at https://doi.org/10.1007/s11325-026-03847-0.
Introduction
Obstructive sleep apnea (OSA) is a very prevalent condition, particularly among psychiatric patients [1–4], where it poses serious health risks such as increased mortality, reduced quality of life, and heightened susceptibility to depression [5–7]. Early identification and management of OSA are critical in psychiatric populations due to its potential to exacerbate the course of psychiatric disorders, such as depression [8, 9].
OSA is typically diagnosed using a sequential algorithm, starting with a structured clinical history and examination, followed by assessment with a polygraphy device, also referred to as a home sleep apnea test (HSAT), and confirmation of diagnosis and treatment initiation with in-lab polysomnography (PSG) [10–12]. As instrument-based diagnostics are resource-intensive and may not be readily available in all clinical settings, tools for structured clinical histories and examinations are of great importance. Consequently, screening questionnaires, such as the STOP-Bang, BOAH, GOAL, NoSAS and No-Apnea scores, have been developed. These questionnaires identify patients at high risk for OSA based on self-report of symptoms (e.g., snoring, daytime sleepiness, and observed apneas) and common risk factors (e.g., body mass index (BMI), age, gender, and hypertension) [13–20].
However, applying these tools to specific subgroups, such as psychiatric patients, introduces challenges. OSA symptoms like fatigue, mood disturbances, and cognitive impairment frequently overlap with psychiatric symptoms [21–23], complicating the clinical screening process. As symptom interpretation is affected by comorbidities, this may reduce the reliability of screening tools in psychiatric populations [24]. To date, most screening tools have not been specifically validated in psychiatric patients. To address this issue, we assessed the diagnostic accuracy of OSA screening questionnaires in a cohort of psychiatric patients in a previous study, revealing high sensitivity, but low specificity [25].
Older patients face additional challenges in the assessment of sleep apnea: According to the current International Classification of Sleep Disorders (ICSD-3-TR), OSA in adults is diagnosed at an Apnea-Hypopnea Index (AHI) of ≥ 15 events per hour, or at an AHI of ≥ 5 events per hour when accompanied by typical nocturnal observations, such as snoring or witnessed apneas, or by symptoms leading to impaired sleep-related quality of life, such as sleepiness, fatigue, or insomnia [26]. In contrast to the previous version, comorbidities alone are no longer sufficient to establish the diagnosis, which places greater weight on the correct attribution of symptoms. In older patients, however, potential OSA symptoms such as fatigue and sleepiness overlap with typical signs of aging, and older OSA patients may exhibit atypical or less pronounced OSA symptoms [27]. Moreover, conditions frequently associated with OSA, such as hypertension, coronary artery disease, stroke, heart failure, atrial fibrillation, type 2 diabetes mellitus, mood disorders, or cognitive impairment [28–30], are significantly more prevalent in older adults, even in the absence of OSA [31–33], which may further complicate symptom attribution and reduce the discriminative value of comorbidity-based questionnaire items. Consequently, the specificity of screening tools is lower in older patients [34]. To address this, adaptions of the current standard screening questionnaires for older patients have been proposed, including the STOP-B28 questionnaire, an adaption of the STOP-Bang questionnaire [35]. However, there is limited evidence regarding the validity of screening questionnaires in the subgroup of older psychiatric patients, where diagnosing and treating OSA is critically important due to the high prevalence and significant impact on both physical and mental health.
This study aims to address this gap by comparing the diagnostic accuracy of the STOP-Bang, STOP-B28, BOAH, GOAL, NoSAS, and No-Apnea questionnaires between younger (aged < 65 years) and older (aged ≥ 65 years) psychiatric inpatients. We hypothesize that age-related physiological changes, the overlap of OSA symptoms with aging and psychiatric symptoms, and differing comorbidity profiles impair questionnaire performance in the older group, which would limit the clinical utility of questionnaire-based screening and support the need for age-adapted screening strategies.
Methods
Study subjects and study design
This observational cohort study is part of the UKER-OSA-PS study (Universitätsklinikum Erlangen study of obstructive sleep apnea in psychiatric patients), previously described in detail [25, 36]. The study included consecutive patients admitted to the private psychiatric ward at University Hospital Erlangen, Germany, between June 1, 2016, and December 31, 2022.
Eligibility criteria
Inclusion criteria were adult patients (≥ 18 years) admitted with a psychiatric diagnosis confirmed by ICD-10 criteria [Organic and Neurodegenerative Disorders (F00.x; F01.x; F02.x; F03; F04; F05.x; F06.x; F07); Substance Use Disorders (F10.x-F19.x), Psychotic Disorders (F20.x; F21; F22.x; F23.x; F24; F25.x); Affective Disorders (F30.x; F31.x; F32.x; F33.x; F34.x); Unipolar Depressive Disorder (F32.x; F33.x); Bipolar Disorder (F30.x; F31.x); Neurotic, Stress-related and Somatoform Disorders (F40.x-F48.x)] [37] and capable of completing the STOP-Bang questionnaire and undergoing polygraphy. Exclusion criteria included a prior OSA diagnosis, incomplete data for questionnaire calculations, or insufficient polygraphy recording time (< 4 h for flow or pulse signals).
Age-based grouping
To assess the effect of age on the diagnostic accuracy of OSA screening tools, patients were stratified into “older” (≥ 65 years) and “younger” (< 65 years) patients in accordance with the German Society for Geriatrics guidelines, which define older adults as those aged 65 years or older [38].
Procedures
Diagnostic algorithm
At admission all patients completed the STOP-Bang questionnaire. Per local protocol, overnight polygraphy was recommended for patients with STOP-Bang ≥ 3 or when clinicians documented a clinical suspicion of OSA; polygraphy was therefore not applied uniformly to all admissions. Overnight polygraphy was performed with the Somnocheck micro CARDIO® home sleep apnea testing device (Weinmann GmbH, Hamburg, Germany), which has been validated against PSG in psychiatric inpatients, as previously described [25, 36]. Polygraphy/HSAT is an accepted diagnostic modality for OSA per current AASM guidelines [39]. In addition, the device derives an autonomic arousal index (AAI) from the photoplethysmographic pulse wave signal, defined as a pulse rate increase ≥ 20%, a pulse wave amplitude attenuation ≥ 40%, or a pulse wave amplitude attenuation ≥ 35% combined with a pulse rate increase ≥ 15% relative to baseline [40].
Questionnaires
All eligible patients completed the STOP-Bang questionnaire at the time of admission. All data required to calculate the STOP-B28, BOAH, GOAL, NoSAS and No-Apnea scores were available. A detailed description and analysis of the questionnaires can be found in a previous publication [25] and in Supplementary Table 1.
STOP-Bang and STOP-B28 questionnaires
The STOP-Bang questionnaire includes 8 questions regarding snoring, tiredness, observed apneas, high blood pressure, body mass index (BMI > 35 kg/m²), age (> 50 years), neck circumference (> 41 cm for females, > 43 cm for males), and male gender. A total score of ≥ 5 indicates a high risk, 3–4 indicates intermediate risk, and ≤ 2 indicates low risk [14, 15]. The STOP-B28 questionnaire, a modified version of the STOP-Bang score developed specifically for older patients, excludes the items age, neck circumference and gender, and uses a lower cut-off for obesity (BMI > 28 kg/m2) [41]. A STOP-B28 score of 0 or 1 is considered low risk for OSA.
BOAH questionnaire
The BOAH score assesses OSA risk using four variables: BMI, observed apneas, age, and hypertension. Points are assigned as follows: BMI ≥ 30 kg/m² (1 point) or ≥ 35 kg/m² (2 points); self-reported observed apneas (1 point); age ≥ 50 years (1 point); and arterial hypertension (1 point). Elevated risk of OSA is indicated by a total score of 2 or more points [16, 42].
GOAL questionnaire
The GOAL questionnaire uses four parameters: male gender (1 point), obesity (BMI ≥ 30 kg/m², 1 point), age ≥ 50 years (1 point), and loud snoring (1 point). A high risk of OSA is indicated by a score of 2 or more points [17, 18].
NoSAS questionnaire
The NoSAS score combines five variables: neck circumference (> 40 cm, 4 points), obesity (BMI 25–29.9 kg/m², 3 points; BMI ≥ 30 kg/m², 5 points), snoring (2 points), age (> 55 years, 4 points), and male gender (2 points). A high risk of OSA is indicated by a total score of 8 or more points [19].
No-Apnea questionnaire
The No-Apnea score evaluates risk based solely on neck circumference and age. Points are assigned as follows: neck circumference 37.0–39.9 cm (1 point), 40.0–42.9 cm (3 points), or ≥ 43.0 cm (6 points); and age 35–44 years (1 point), 45–54 years (2 points), or ≥ 55 years (3 points). A score of ≥ 3 indicates a high risk of OSA [20].
Analysis
Data acquisition
Demographics, comorbidities, and in-hospital metrics were extracted from digitalized medical records using standardized protocols. In addition to general clinical data (age, sex, body-mass index) and medical comorbidities (e.g., hypertension, diabetes, cardiovascular disease), we recorded psychiatric characteristics including principal psychiatric diagnosis, current psychotropic medication, and Beck Depression Inventory-II (BDI-II) score at admission. The primary outcome was the diagnostic accuracy of each questionnaire, measured by sensitivity, specificity, and area under the ROC curve (AUC) at AHI ≥ 5 events/hour. This study was conducted according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines [43].
Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics, version 29.0, and Microsoft Excel, version 2019. Categorical variables are reported as counts (percentages) and were compared with the χ² test or Fisher’s exact test, as appropriate. Continuous variables are presented as medians [interquartile ranges (IQRs)] and were compared between groups using the Mann-Whitney U test. All tests were two-sided and p < 0.05 was considered statistically significant. To assess diagnostic accuracy, the area under the receiver operating characteristic (ROC) curve was analyzed and sensitivity (proportion of true positives among all individuals with the condition; true positive / [true positive + false negative]) and specificity (proportion of true negatives among all individuals without the condition; true negative / [true negative + false positive]) were calculated through cross-tabulation. 95% confidence intervals for sensitivity and specificity were calculated using the Wilson score method. To explore the discriminative value of individual predictors in the entire cohort, ROC curves were calculated for the continuous variables age, BMI, and neck circumference, and sensitivity and specificity were calculated for the binary items snoring, daytime tiredness, observed apneas, hypertension, and male sex.
Results
Study population and baseline characteristics
A total of 141 patients were included in this study (Fig. 1). Thirteen patients were excluded due to insufficient polygraphy quality. Overall, there were 128 patients included in the final analysis: 72 younger patients aged 18–64 years and 56 older patients aged ≥ 65 years (Table 1). The median age was 53.5 years [IQR, 40.0–59.0] for younger patients and 75.0 years [IQR, 71.0–77.8] for older patients (p < 0.001). Female patients made up 38.9% [28/72] of the younger group and 41.1% [23/56] of the older group (p = 0.8). Neither the median duration of hospital stay (34.5 days [IQR, 17.3–49.0] vs. 28.5 days [IQR, 3.5–43.8]; p = 0.2) nor the median interval between admission and polygraphy (2.0 days [IQR, 0.0–4.8] vs. 1.0 day [IQR, 0.0–5.0]; p = 0.6) differed significantly between younger and older patients.
Table 1Baseline demographics and clinical characteristics
Variable Younger PatientsAge: 18–64(n = 72) Older PatientsAge ≥ 65(n = 56) p
Demographics
Sex
Female, No. (%) 28 (38.9) 23 (41.1) 0.8
Male, No. (%) 44 (61.1) 33 (58.9) 0.8
Age, median (IQR), y 53.5 (40.0–59.0) 75.0 (71.0–77.8) < 0.001
Adiposity
BMI, median (IQR), kg/m2 27.6 (23.6–31.3) 26.1 (23.0–28.1) 0.03
BMI 30–34.9 kg/m2, No. (%) 13 (18.1) 5 (8.9) 0.1
BMI 35–39.9 kg/m2, No. (%) 6 (8.3) 3 (5.4) 0.7
BMI ≥ 40 kg/m2, No. (%) 4 (5.6) 0 (0.0) 0.1
BDI-II score at Admission, median (IQR) a 27.0 (17.5–37.0) 20.0 (8.0–26.8) 0.003
Duration of Stay, median (IQR), d 34.5 (17.3–49.0) 28.5 (3.5–43.8) 0.2
Interval Admission to Polygraphy, median (IQR), d 2.0 (0.0–4.8) 1.0 (0.0–5.0) 0.6
Private Insurance, No. (%) 62 (86.1) 52 (92.9) 0.2
Psychiatric Diagnoses
Organic and Neurodegenerative Disorders, No. (%) 13 (18.1) 20 (35.7) 0.02
Substance Use Disorders, No. (%) 15 (20.8) 13 (23.2) 0.8
Psychotic Disorders, No. (%) 2 (2.8) 2 (3.6) 0.8
Affective Disorders, No. (%) 59 (81.9) 41 (73.2) 0.2
Unipolar Depressive Disorder, No. (%) 55 (76.4) 38 (67.9) 0.3
Bipolar Disorder, No. (%) 4 (5.6) 3 (5.4) > 0.95
Neurotic/Stress-related/Somatoform disorders, No. (%) 26 (36.1) 18 (32.1) 0.6
Non-psychiatric Diagnoses
Pulmonary Diseases, No. (%) 6 (8.3) 6 (10.7) 0.7
COPD, No. (%) 1 (1.4) 2 (3.6) 0.6
Asthma, No. (%) 5 (6.9) 2 (3.6) 0.5
Cardiovascular Diseases, No. (%) 32 (44.4) 46 (82.1) < 0.001
Arterial Hypertension, No. (%) 30 (41.7) 43 (76.8) < 0.001
Atrial Fibrillation, No. (%) 2 (2.8) 9 (16.1) 0.01
Kidney Disorders, No. (%) 5 (6.9) 9 (16.1) 0.1
Hypothyroidism, No. (%) 15 (20.8) 10 (17.9) 0.7
Substance Use History, No. (%) b 44 (61.1) 23 (41.1) 0.02
Active Nicotine Use, No. (%) c 25 (34.7) 9 (16.1) 0.02
Former Smoker, No. (%) d 8 (11.1) 8 (14.3) 0.6
Regular Alcohol Consumption, No. (%) e 20 (27.8) 12 (21.4) 0.4
Cannabis or Illicit Substance Use, No. (%) f 13 (18.1) 3 (5.4) 0.03
a. Data available for 57 of 72 younger patients and 46 of 56 older patients
b. Substance Use History was defined as a self-reported prior use of nicotine, alcohol, cannabis or illicit substances
c. Active Nicotine Use was defined as self-reported current use of nicotine products or abstinence shorter than six months
d. Former smokers were defined as individuals with a self-reported history of smoking who had abstained for more than six months
e. Regular alcohol consumption was defined as self-reported drinking on at least three days per week
f. Cannabis or illicit substance use was defined as any self-reported use of cannabis or other illegal drugs at admission
Continuous and ordinal variables are reported as median (IQR); categorical variables as n (%). P values were obtained using Mann–Whitney U test for continuous variables and χ² test or Fisher’s exact test for categorical variables, as appropriate. BMI body mass index, No. number, BDI-II Beck Depression Inventory-II, COPD chronic obstructive pulmonary disease
The median BMI was significantly higher in younger patients (27.6 kg/m² [IQR, 23.6–31.3]) compared to older patients (26.1 kg/m² [IQR, 23.0–28.1]; p = 0.03). Grade 1 obesity (BMI 30–34.9 kg/m²) was present in 18.1% [13/72] of younger patients and 8.9% [5/56] of older patients (p = 0.1), while grade 2 obesity (BMI 35–39.9 kg/m²) was found in 8.3% [6/72] and 5.4% [3/56], respectively (p = 0.7).
Among psychiatric diagnoses, organic and neurodegenerative disorders were significantly more common in older patients (35.7% [20/56]) than in younger patients (18.1% [13/72]; p = 0.02). Affective disorders were the most common psychiatric diagnoses in both groups, affecting 81.9% [59/72] of younger patients and 73.2% [41/56] of older patients (p = 0.2). Among these, unipolar depressive disorder was the predominant subtype, observed in 76.4% [55/72] of younger patients and 67.9% [38/56] of older patients (p = 0.3). The BDI-II score at admission was significantly higher in younger patients (27.0 [IQR, 17.5–37.0]) than in older patients (20.0 [IQR, 8.0–26.8]; p = 0.003). In addition, we documented the use of major psychiatric medication classes (antidepressants, antipsychotics, lithium, sedatives, anticonvulsants, and antidementia drugs) at the time of admission. No significant differences in medication use were observed between age groups (Supplementary Table 2).
Cardiovascular diseases were significantly more common in older patients, affecting 82.1% [46/56] compared to 44.4% [32/72] of younger patients (p < 0.001). Among these, arterial hypertension was observed in 76.8% [43/56] of older patients and 41.7% [30/72] of younger patients (p < 0.001). Additionally, atrial fibrillation occurred more frequently in older patients (16.1% [9/56]) compared to younger patients (2.8% [2/72]; p = 0.01).
Substance use history was more common in younger patients (61.1% [44/72] vs. 41.1% [23/56]; p = 0.02), particularly illicit drug or cannabinoid use, which was reported in 18.1% [13/72] of younger patients and 5.4% [3/56] of older patients (p = 0.03), as well as active nicotine use, observed in 34.7% [25/72] of younger patients compared to 16.1% [9/56] of older patients (p = 0.02).
OSA questionnaire and polygraphy results
Screening questionnaire scores did not differ significantly between younger and older patients for STOP-Bang (3.0 [IQR, 3.0–5.0] vs. 4.0 [IQR, 3.0–5.0]; p = 0.3), STOP-B28 (3.0 [IQR, 2.0–3.0] vs. 2.0 [IQR, 2.0–3.0]; p = 0.2), GOAL (3.0 [IQR, 2.0–3.0] vs. 2.0 [IQR, 2.0–3.0]; p = 0.6), and No-Apnea (4.5 [IQR, 3.0–8.0] vs. 4.0 [IQR, 3.0–6.0]; p = 0.4) (Table 2). Due to the sequential screening algorithm, where polygraphy was performed in patients with elevated OSA risk according to clinical screening including the STOP-Bang score, there was an elevated score range in both subgroups. There were significant differences in the BOAH and NoSAS questionnaire scores between the two age groups: The median BOAH score was 2.0 [IQR, 1.0–3.0] in younger patients compared to 2.0 [IQR, 2.0–3.0] in older patients (p = 0.04), reflecting an elevated and more concentrated score range among older patients. The NoSAS score was significantly lower in older patients (5.0 [IQR, 3.0–11.0]) compared to younger patients (10.0 [IQR, 4.0–11.0]; p = 0.02).
Table 2Questionnaire scores and overnight polygraphic examination data
Variable Younger PatientsAge: 18–64(n = 72) Older PatientsAge ≥ 65(n = 56) p
Questionnaire Data
STOP–Bang score, median (IQR) 3.0 (3.0–5.0) 4.0 (3.0–5.0) 0.3
STOP–B28 score, median (IQR) 3.0 (2.0–3.0) 2.0 (2.0–3.0) 0.2
BOAH score, median (IQR) 2.0 (1.0–3.0) 2.0 (2.0–3.0) 0.04
GOAL score, median (IQR) 3.0 (2.0–3.0) 2.0 (2.0–3.0) 0.6
NoSAS score, median (IQR) 10.0 (4.0–11.0) 5.0 (3.0–11.0) 0.02
No–Apnea score, median (IQR) 4.5 (3.0–8.0) 4.0 (3.0–6.0) 0.4
Polygraphic Examination Data
Apneas and Hypopneas
Apnea–Hypopnea–Index (AHI), median (IQR), events/h 1.8 (0.5–5.6) 7.7 (4.8–15.5) 0.007
Any OSA, No. (%) a 34 (47.2) 41 (73.2) 0.003
Moderate to Severe OSA, No. (%) a 8 (11.1) 16 (28.6) 0.01
Severe OSA, No. (%) a 2 (2.8) 4 (7.1) 0.4
Apnea–Index (AI), median (IQR), events/hb 1.3 (0.5–4.0) 4.1 (2.0–11.8) < 0.001
Hypopnea–Index (HI), median (IQR), events/hb 2.8 (1.3–4.7) 3.1 (1.8–5.7) 0.2
Longest Apnea, median (IQR), sb 19.5 (15.0–32.5) 31.0 (23.0–46.0) < 0.001
Mean Apnea duration, median (IQR), sb 14.0 (12.0–16.0) 16.0 (15.0–19.0) < 0.001
Snoring, median (IQR), % of measured timeb 5.5 (0.0–20.5) 5.0 (1.0–15.5) 0.9
Oxygen Saturation
Oxygen–Desaturation–Index (ODI), median (IQR), events/h 1.6 (0.5–4.0) 4.1 (1.2–8.2) 0.007
Duration below 95% SpO2, median (IQR), % of measured time 11.0 (2.0–53.5) 38.5 (17.3–87.8) < 0.001
Min. SpO2, median (IQR), % 85.0 (80.0–89.0) 83.0 (79.0–85.8) 0.05
Average SpO2, median (IQR), % 95.0 (94.0–96.0) 94.0 (92.3–95.0) < 0.001
Pulse Oximetry Data
Average Pulse, median (IQR), bpm 65.0 (57.0–69.8) 63.5 (58.0–70.0) 0.8
Min. Pulse, median (IQR), bpm 44.0 (39.3–48.8) 46.0 (40.3–50.0) 0.2
Max. Pulse, median (IQR), bpm 96.0 (89.3–105.0) 93.0 (87.0–98.8) 0.03
a. Any OSA: AHI ≥ 5; Moderate to Severe OSA: AHI ≥ 15; Severe OSA: AHI ≥ 30
b. Data available for 60 of 72 younger patients and 49 of 56 older patients
Continuous variables are shown as median (IQR); categorical variables as n (%). P values were calculated using Mann–Whitney U test, χ² test, or Fisher’s exact test, as appropriate. SpO₂ = peripheral oxygen saturation
Obstructive sleep apnea (OSA) was significantly more prevalent in older patients compared to younger patients: The median AHI was significantly higher in older patients (7.7 events/h [IQR, 4.8–15.5]) than in younger patients (1.8 events/h [IQR, 0.5–5.6]; p = 0.007). Any OSA (AHI ≥ 5) was present in 73.2% [41/56] of older patients and 47.2% [34/72] of younger patients (p = 0.003). Moderate to severe OSA (AHI ≥ 15) occurred in 28.6% [16/56] of older patients and 11.1% [8/72] of younger patients (p = 0.01). The proportion of patients with severe OSA (AHI ≥ 30) was low in both groups, affecting 7.1% [4/56] of older patients and 2.8% [2/72] of younger patients (p = 0.4).
Apart from the higher prevalence, OSA severity was also greater in older patients: Both the mean apnea duration (16.0 s [IQR, 15.0–19.0]) and the longest apnea duration (31.0 s [IQR, 23.0–46.0]) were significantly longer in older patients compared to younger patients (14.0 s [IQR, 12.0–16.0] and 19.5 s [IQR, 15.0–32.5]; p < 0.001 for both). Additionally, older patients exhibited a higher desaturation index (4.1 events/h [IQR, 1.2–8.2] vs. 1.6 events/h [IQR, 0.5–4.0]; p = 0.007), longer duration below 95% SpO₂ (38.5% [IQR, 17.3–87.8] vs. 11.0% of measured time [IQR, 2.0–53.5]; p < 0.001), and a lower minimum SpO₂ (83.0% [IQR, 79.0–85.8] vs. 85.0% [IQR, 80.0–89.0]; p = 0.05). The autonomic arousal index (AAI), a pulse wave–derived marker of autonomic activation, was higher in younger patients (19.2 events/h [IQR, 12.8–27.7]) compared to older patients (7.3 events/h [IQR, 4.5–10.1]; p < 0.001). However, in data from our previous validation study of the device, the AAI was not correlated with the PSG arousal index (Supplementary Table 3).
Receiver operating characteristic curve analysis
Receiver Operating Characteristic (ROC) curves were used to compare the diagnostic accuracy of screening questionnaires for the diagnosis of any OSA (AHI ≥ 5 events/h) between younger and older patients (Fig. 2). In our screened cohort, the Area Under the Curve (AUC) values were lower in older patients for all questionnaires, with Δ AUCs ranging from 0.12 to 0.36 (Table 3). The No-Apnea score, which displayed the highest AUC in younger patients of 0.78 [95% CI, 0.67–0.89], showed a lower AUC of 0.48 [95% CI, 0.31–0.66; Δ AUC, 0.30; p = 0.005] in older patients. Significantly lower AUCs were also observed in older patients in the STOP-Bang (younger patients, AUC, 0.75 [95% CI, 0.64–0.87] vs. older patients, AUC, 0.48 [95% CI, 0.30–0.65]; Δ AUC, 0.28; p = 0.009) and GOAL questionnaires (younger patients, AUC, 0.73 [95% CI, 0.62–0.85] vs. older patients, AUC, 0.38 [95% CI, 0.20–0.55]; Δ AUC, 0.36; p = 0.001); and a similar trend was observed for NoSAS (younger patients, AUC, 0.71 [95% CI, 0.59–0.83] vs. older patients, AUC, 0.49 [95% CI, 0.30–0.67]; Δ AUC, 0.22; p = 0.05). The STOP-B28 score, despite being designed for older patients, did not demonstrate superior performance in this group compared to the other questionnaires and exhibited the lowest AUC in younger patients (younger patients, AUC, 0.61 [95% CI, 0.47–0.74] vs. older patients, AUC, 0.49 [95% CI, 0.32–0.66]; Δ AUC, 0.12; p = 0.3). The BOAH questionnaire had the highest accuracy in older patients among all the questionnaires (younger patients, AUC, 0.74 [95% CI, 0.63–0.86] vs. older patients, AUC, 0.59 [95% CI, 0.42–0.76]; Δ AUC, 0.15; p = 0.1). ROC analysis for moderate to severe OSA (AHI ≥ 15 events/h) revealed no significant differences between younger and older patients (Supplementary Fig. 1 and Supplementary Table 4). However, the reliability of this finding is limited by the low number of patients in the category of moderate to severe OSA (8 younger patients and 16 older patients).
Table 3Comparison of the area under the receiver operating characteristic curves for any OSA (AHI ≥ 5)
Questionnaire AUC (95% CI) AUC (95% CI) Δ AUC p
Younger Patients Older Patients
STOP-Bang 0.75
(0.64–0.87)
0.48
(0.30–0.65)
0.28 0.009
STOP-B28 0.61
(0.47–0.74)
0.49
(0.32–0.66)
0.12 0.3
BOAH 0.74
(0.63–0.86)
0.59
(0.42–0.76)
0.15 0.1
GOAL 0.73
(0.62–0.85)
0.38
(0.20–0.55)
0.36 0.001
NoSAS 0.71
(0.59–0.83)
0.49
(0.30–0.67)
0.22 0.05
No-Apnea 0.78
(0.67–0.89)
0.48
(0.31–0.66)
0.30 0.005
ΔAUC indicates difference between AUCs; AHI apnea–hypopnea index, AUC area under the curve
Diagnostic performance of the questionnaires
Diagnostic performance of each questionnaire for detecting OSA (AHI ≥ 5 events/h) is presented in Table 4. Overall, accuracy was consistently higher in younger patients across most questionnaires. For the STOP‑Bang score at cut‑off ≥ 3, sensitivity was similar in both age cohorts (younger patients, 91.2% vs. older patients, 90.2%), but specificity was higher in younger patients (younger patients, 18.4% vs. older patients, 6.7%). Raising the cut-off to ≥ 4 led to a substantial increase in specificity among younger patients (younger patients, 68.4% vs. older patients, 33.3%), while sensitivity was comparable between the cohorts (younger patients, 67.6% vs. older patients, 61.0%). The STOP‑B28, designed for older adults, showed nearly identical performance at cut‑off ≥ 2 in both groups (younger patients: sensitivity, 79.4%, specificity, 18.4% vs. older patients: sensitivity, 78.0%, specificity, 20.0%), though its sensitivity was lower than that of the original STOP‑Bang in both groups. Among the remaining tools, only the BOAH score achieved higher sensitivity in older patients at its primary threshold of ≥ 2 (younger patients, 73.5% vs. older patients, 87.8%), but specificity was lower (younger patients, 60.5% vs. older patients, 26.7%). Both the GOAL (younger patients: sensitivity, 97.1%, specificity, 26.3% vs. older patients: sensitivity, 87.8%, specificity, 13.3%) and NoSAS (younger patients: sensitivity, 82.4%, specificity, 39.5% vs. older patients: sensitivity, 68.3%, specificity, 20.0%) questionnaires performed better in younger patients. By design, all older patients scored ≥ 3 on the No‑Apnea score; at this threshold its sensitivity in younger patients reached 91.2% with 23.7% specificity. Increasing the cut‑off to ≥ 4 balanced performance in younger patients (sensitivity 82.4%, specificity 52.6%), while it remained poor in older patients (sensitivity 73.2%, specificity 20.0%).
Table 4Predictive performance of questionnaires for AHI ≥ 5
Questionnaire Cut-off Younger Patients Older Patients
Sensitivity Specificity Sensitivity Specificity
STOP-Bang ≥ 3 91.2 (77.0–97.0) 18.4 (9.2–33.4) 90.2 (77.5–96.1) 6.7 (1.2–29.8)
≥ 4 67.6 (50.8–80.9) 68.4 (52.5–80.9) 61.0 (45.7–74.3) 33.3 (15.2–58.3)
≥ 5 52.9 (36.7–68.5) 92.1 (79.2–97.3) 36.6 (23.6–51.9) 66.7 (41.7–84.8)
STOP-B28 ≥ 2 79.4 (63.2–89.7) 18.4 (9.2–33.4) 78.0 (63.3–88.0) 20.0 (7.0–45.2)
≥ 3 58.8 (42.2–73.6) 52.6 (37.3–67.5) 41.5 (27.8–56.6) 53.3 (30.1–75.2)
BOAH ≥ 2 73.5 (56.9–85.4) 60.5 (44.7–74.4) 87.8 (74.5–94.7) 26.7 (10.9–52.0)
≥ 3 44.1 (28.9–60.5) 89.5 (75.9–95.8) 26.8 (15.7–41.9) 80.0 (54.8–93.0)
GOAL ≥ 2 97.1 (85.1–99.5) 26.3 (15.0–42.0) 87.8 (74.5–94.7) 13.3 (3.7–37.9)
≥ 3 70.6 (53.8–83.2) 63.2 (47.3–76.6) 39.0 (25.7–54.3) 33.3 (15.2–58.3)
NoSAS ≥ 8 82.4 (66.5–91.7) 39.5 (25.6–55.3) 68.3 (53.0–80.4) 20.0 (7.0–45.2)
≥ 9 82.4 (66.5–91.7) 47.4 (32.5–62.7) 63.4 (48.1–76.4) 46.7 (24.8–69.9)
≥ 10 76.5 (60.0–87.6) 52.6 (37.3–67.5) 48.8 (34.3–63.5) 60.0 (35.7–80.2)
No-Apnea ≥ 3 91.2 (77.0–97.0) 23.7 (13.0–39.2) 100 (91.4–100) 0 (0–20.4)
≥ 4 82.4 (66.5–91.7) 52.6 (37.3–67.5) 73.2 (58.1–84.3) 20.0 (7.0–45.2)
≥ 5 73.5 (56.9–85.4) 71.1 (55.2–83.0) 48.8 (34.3–63.5) 60.0 (35.7–80.2)
Values are given as % (95% CI). Validity indices were calculated for OSA defined as AHI ≥ 5. 95% confidence intervals were calculated using the Wilson score method. AHI apnea–hypopnea index, CI confidence interval
Age and other questionnaire components as predictors of OSA
ROC curve analysis was used to investigate age, BMI, and neck circumference as predictors of OSA (Fig. 3) in the entire cohort (n = 128). Here, age alone yielded an AUC of 0.70 [95% CI, 0.61–0.80] for the detection of any OSA (AHI ≥ 5 events/h), which exceeded the AUCs observed for several questionnaires in older patients. In contrast, neck circumference showed poor discrimination (AUC, 0.61 [95% CI, 0.51–0.71]; p = 0.03), and BMI did not discriminate significantly (AUC, 0.56 [95% CI, 0.46–0.66]; p = 0.3). Among binary items, the symptom-based items snoring, daytime tiredness, and observed apneas as well as male sex showed low discriminative value, with either low sensitivity or low specificity, whereas hypertension showed the most balanced profile (sensitivity, 69.3%; specificity, 54.7%) (Supplementary Table 5).
Discussion
In this cohort of psychiatric inpatients at risk for OSA, obstructive sleep apnea (OSA) was both more prevalent and more severe in patients aged ≥ 65 years than in those < 65 years. Older patients showed higher median apnea–hypopnea indices, more pronounced desaturations, and longer apneic events. These observations are consistent with epidemiologic data identifying age as a strong risk factor for OSA [44–46], and underscore the clinical importance of early and accurate OSA detection in older psychiatric patients. Despite the greater objectively measured disease burden, median scores on the STOP-Bang, STOP-B28, BOAH, GOAL, NoSAS, and No-Apnea questionnaires were not higher in the older subgroup of psychiatric inpatients.
Receiver operating characteristic (ROC) analysis in the screened cohort showed greater discriminative accuracy of most questionnaires in younger than in older patients. In younger patients, AUCs for STOP-Bang, No-Apnea, NoSAS, and GOAL ranged from 0.71 to 0.78, modestly lower than the 0.86–0.94 (AHI ≥ 5) reported in sleep-clinic populations [17], but comparable to data from cohorts with major depressive disorder (0.73–0.77 for AHI ≥ 5) [47]. In older patients, absolute AUCs declined by 0.12 to 0.36 points. The BOAH questionnaire showed the highest AUC (0.59), whereas all other instruments performed poorly (AUCs 0.38–0.49, with confidence intervals including 0.5, indicating discrimination not better than chance). Because of the sequential diagnostic algorithm, absolute AUC estimates should be interpreted with caution; however, the relative decline in discrimination with advancing age in the verified cohort is notable and merits further evaluation.
The reduced discriminative performance of screening questionnaires in the subgroup of older patients appeared to be driven mainly by lower specificity rather than lower sensitivity: For instance, at its primary threshold of ≥ 2, the BOAH score showed higher sensitivity in older than in younger patients (87.8% vs. 73.5%), whereas specificity was lower (26.7% vs. 60.5%). Analogous age-related declines in specificity were evident for the STOP-Bang, GOAL, and No-Apnea instruments, consistent with prior reports in older cohorts [35]. Given the wide confidence intervals, particularly for specificity in older patients, these differences should be interpreted with caution.
There are few studies that have evaluated OSA screening questionnaire performance specifically in older adults, and none to our knowledge in a psychiatric population. In sleep-clinic cohorts the results are heterogeneous. In a Brazilian sleep clinic series that used a combined symptom + AHI definition of OSA, STOP-Bang retained robust discrimination in patients aged ≥ 60 years (AUC, 0.80; Sensitivity, 0.89; Specificity, 0.42) [48]. Another Brazilian sleep clinic study reported a STOP-Bang sensitivity of 0.71 and specificity of 0.41 for AHI ≥ 5 in older patients [49]. By contrast, Martins et al. found lower AUCs in an older cohort of community-dwelling adults aged ≥ 65 years: STOP-Bang and STOP-B28 yielded AUCs of around 0.64 for AHI ≥ 5 [35]. A validation study in patients with Parkinson disease reported AUCs of 0.66–0.76 for STOP-Bang, STOP-B28 and GOAL, but these estimates referred to AHI ≥ 15 and the mean age (≈ 64.5 years) was lower than that of our older subgroup, limiting direct comparison [41].
In summary, in our screened cohort of older psychiatric inpatients, the discriminative performance of screening questionnaires appeared lower than that reported in some non-psychiatric geriatric samples, though direct comparison is limited by differences in study design. While the sequential diagnostic algorithm with preferential testing of high-risk patients may have biased specificity and AUC downward in our sample, the relative deficit in older patients may also reflect factors specific to psychiatric inpatients. Symptom overlap may be a major contributor: fatigue, excessive daytime sleepiness, and cognitive dysfunction are core features of OSA but also occur in depression and other psychiatric disorders [23, 50]. This can inflate affirmative responses to symptom-based questionnaire items and increase false-positive rates, particularly in older patients. Consistent with this, symptom-based items such as snoring and daytime tiredness showed low discriminative value in our cohort. In older psychiatric patients this problem is compounded because OSA symptoms further overlap with common manifestations of aging, making correct attribution even more difficult [27]. Finally, the high prevalence of neurodegenerative disease in our cohort of older psychiatric inpatients may suggest cognitive heterogeneity that could influence questionnaire validity, though formal cognitive assessment was not available. Cognitive deficits may reduce the validity of self-reported histories through impaired recall, reduced insight, and response bias, eroding specificity and overall test discrimination [51, 52].
Psychotropic medication may have influenced both polygraphic findings and questionnaire responses. Benzodiazepines and Z-drugs can reduce upper airway muscle tone and arousal responses, and sedating antipsychotics and some antidepressants are associated with weight gain, all of which may aggravate sleep-disordered breathing [53, 54]. In addition, sedating medication may contribute to daytime tiredness and thereby to positive responses on symptom-based questionnaire items. In our sample, the use of major psychotropic medication classes at admission did not differ between younger and older patients, and polygraphy was performed early after admission (median interval, 1–2 days), so that medication at admission likely reflected medication during the recording night in most patients. Medication effects are therefore unlikely to account for the age-related differences in questionnaire performance observed in our study, although they may have influenced absolute estimates in both age groups. However, dosages, polypharmacy, and medication changes between admission and polygraphy could not be systematically assessed, and residual confounding by psychotropic medication cannot be excluded.
Another factor that may account for discrepant questionnaire performance is heterogeneity in the OSA reference definition. In line with previous validation studies of OSA screening questionnaires, OSA was defined by AHI thresholds, providing an objective reference standard that is independent of symptom reporting. According to the ICSD-3-TR, symptoms establishing the diagnosis of OSA at an AHI of 5–14 events/h include, among others, sleepiness, fatigue, insomnia, or other symptoms impairing sleep-related quality of life, as well as awakenings with breath holding, gasping, or choking [26]. Such symptoms are highly prevalent among psychiatric inpatients, particularly in those with depressive disorders [55]. We therefore consider AHI ≥ 5 to be of primary clinical relevance in this population, consistent with guideline recommendations to consider positive airway pressure therapy in symptomatic patients with mild OSA [56, 57].
Chronological age yielded an AUC of 0.70 in the ROC analysis of the entire cohort of psychiatric patients at risk for OSA. In contrast, BMI and neck circumference showed poor discrimination, and symptom-based items as well as male sex showed low discriminative value. This finding raises the hypothesis that advancing age may overshadow other conventional risk factors in determining OSA risk among psychiatric inpatients. Our data align with prior epidemiologic work showing that the effectiveness of conventional predictors, notably body-mass index, reported snoring and witnessed apneas, weakens with advancing age [44]. Moreover, male sex, a strong predictor in middle-aged cohorts, loses discriminatory value in older populations, in part because OSA prevalence in postmenopausal women rises and gender prevalence ratios converge with age [58–60]. As these analyses were performed in a cohort preselected for elevated OSA risk, they should be considered exploratory.
Differences in questionnaire design and performance have pragmatic implications. The STOP-B28 score showed low discriminatory accuracy in our sample both in younger (AUC, 0.61) and older (AUC, 0.49) patients. Paradoxically, NoSAS scores were lower among older patients in our sample despite greater OSA severity. This is potentially due to NoSAS’s substantial weighting of adiposity (BMI and neck circumference), which was less prevalent in the older subgroup of our screened cohort, and is consistent with the poor discriminative value of BMI and neck circumference in our cohort. By contrast, the BOAH questionnaire showed the highest AUC (0.59) and a high sensitivity (87.8%) in older patients, albeit with low specificity (26.7%). BOAH’s pragmatic advantages (no neck-circumference measurement required) may support its further evaluation as a quick screening tool in older patients.
In our screened cohort, validated questionnaires remained useful to triage younger psychiatric inpatients at risk for OSA. The No-Apnea questionnaire showed the highest AUC in younger patients, with high sensitivity at a cut-off of ≥ 3 and a more balanced performance at a cut-off of ≥ 4. In older patients in our screened cohort, the limited discrimination of all questionnaires suggests that reliance on questionnaires alone may be inadequate. Given the high prevalence [61], greater severity [62], and frequently atypical presentation of OSA in older patients [63], a lower threshold for direct device-based diagnostics (polygraphy/HSAT or in-lab PSG) may warrant consideration.
Limitations and future directions
This study has several limitations. First, as polygraphy was performed preferentially in patients with STOP-Bang ≥ 3 or with clinical suspicion of OSA, our findings are subject to partial verification bias and spectrum bias and apply to psychiatric inpatients at risk for OSA rather than to all psychiatric admissions. Such sampling increases pre-test probability and may lead to an overestimation of sensitivity and an underestimation of specificity and AUC. However, reported prevalence estimates reach similarly high levels in geriatric samples (e.g., up to 75%) [58, 63] as in our screened cohort of older psychiatric patients at risk for OSA, and limited questionnaire discrimination has also been observed in such samples [35]. Second, the STOP-Bang questionnaire served both as part of the referral criterion and as an index test, which restricts the range of STOP-Bang scores and, to a lesser extent, of other questionnaires sharing items with it. STOP-Bang estimates should therefore be interpreted with particular caution. Third, this was a single-center study with a moderate sample size, particularly in the older subgroup, which limits the precision and generalizability of our estimates. Fourth, OSA was assessed by polygraphy rather than PSG; however, the device has been validated against PSG in this patient population [36], and polygraphy is an accepted diagnostic method for OSA [39].
Prospective studies are therefore warranted to confirm our findings. Specifically, future work should include larger, multicenter cohorts (including outpatient and community settings) with uniform application of device-based reference testing to obtain unbiased estimates of questionnaire accuracy. Studies should also formally quantify the impact of cognitive impairment and neurodegenerative disease on questionnaire reliability and assess whether recalibration or redevelopment of screening instruments improves discrimination in older psychiatric populations. Finally, research should evaluate pragmatic clinical pathways that prioritize early device-based testing for older psychiatric inpatients at elevated risk.
Conclusions
In our cohort of psychiatric inpatients at risk for OSA, screening questionnaires retained moderate discriminative accuracy in younger patients but performed poorly in older patients, largely reflecting lower specificity. Chronological age alone showed moderate discriminative value. Our findings support considering a lower threshold for direct device-based testing in older psychiatric patients at risk for OSA, pending prospective validation.
Supplementary Information
Below is the link to the electronic supplementary material.
6 References
1.Fietze I Laharnar N Obst A Ewert R Felix SB Garcia C Prevalence and association analysis of obstructive sleep apnea with gender and age differences - Results of SHIP-Trend J Sleep Res 2019 28 5 e12770 30272383 10.1111/jsr.12770 Fietze I, Laharnar N, Obst A, Ewert R, Felix SB, Garcia C et al (2019) Prevalence and association analysis of obstructive sleep apnea with gender and age differences - Results of SHIP-Trend. J Sleep Res 28(5):e1277010.1111/jsr.12770 30272383
2.Peppard PE Young T Barnet JH Palta M Hagen EW Hla KM Increased prevalence of sleep-disordered breathing in adults Am J Epidemiol 2013 177 9 1006 1014 23589584 10.1093/aje/kws342 Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM (2013) Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol 177(9):1006–101410.1093/aje/kws342 PMC3639722 23589584
3.Gupta MA Simpson FC Obstructive sleep apnea and psychiatric disorders: a systematic review J Clin Sleep Med 2015 11 2 165 175 10.5664/jcsm.4466 25406268 Gupta MA, Simpson FC (2015) Obstructive sleep apnea and psychiatric disorders: a systematic review. J Clin Sleep Med 11(2):165–17510.5664/jcsm.4466 PMC4298774 25406268
4.Sharafkhaneh A Giray N Richardson P Young T Hirshkowitz M Association of psychiatric disorders and sleep apnea in a large cohort Sleep 2005 28 11 1405 1411 16335330 10.1093/sleep/28.11.1405 Sharafkhaneh A, Giray N, Richardson P, Young T, Hirshkowitz M (2005) Association of psychiatric disorders and sleep apnea in a large cohort. Sleep 28(11):1405–141110.1093/sleep/28.11.1405 16335330
5.Edwards C Almeida OP Ford AH Obstructive sleep apnea and depression: A systematic review and meta-analysis Maturitas 2020 142 45 54 33158487 10.1016/j.maturitas.2020.06.002 Edwards C, Almeida OP, Ford AH (2020) Obstructive sleep apnea and depression: A systematic review and meta-analysis. Maturitas 142:45–5410.1016/j.maturitas.2020.06.002 33158487
6.Newman AB Nieto FJ Guidry U Lind BK Redline S Pickering TG Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study Am J Epidemiol 2001 154 1 50 59 11434366 10.1093/aje/154.1.50 Newman AB, Nieto FJ, Guidry U, Lind BK, Redline S, Pickering TG et al (2001) Relation of sleep-disordered breathing to cardiovascular disease risk factors: the Sleep Heart Health Study. Am J Epidemiol 154(1):50–5910.1093/aje/154.1.50 11434366
7.Batool-Anwar S Goodwin JL Kushida CA Walsh JA Simon RD Nichols DA Impact of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea (OSA) J Sleep Res 2016 25 6 731 738 27242272 10.1111/jsr.12430 Batool-Anwar S, Goodwin JL, Kushida CA, Walsh JA, Simon RD, Nichols DA et al (2016) Impact of continuous positive airway pressure (CPAP) on quality of life in patients with obstructive sleep apnea (OSA). J Sleep Res 25(6):731–73810.1111/jsr.12430 PMC5436801 27242272
8.Jackson ML Tolson J Schembri R Bartlett D Rayner G Lee VV Does continuous positive airways pressure treatment improve clinical depression in obstructive sleep apnea? A randomized wait-list controlled study Depress Anxiety 2021 38 5 498 507 33368782 10.1002/da.23131 Jackson ML, Tolson J, Schembri R, Bartlett D, Rayner G, Lee VV et al (2021) Does continuous positive airways pressure treatment improve clinical depression in obstructive sleep apnea? A randomized wait-list controlled study. Depress Anxiety 38(5):498–50710.1002/da.23131 33368782
9.Waterman L Stahl ST Buysse DJ Lenze EJ Blumberger D Mulsant B Self-reported obstructive sleep apnea is associated with nonresponse to antidepressant pharmacotherapy in late-life depression Depress Anxiety 2016 33 12 1107 1113 27636232 10.1002/da.22555 Waterman L, Stahl ST, Buysse DJ, Lenze EJ, Blumberger D, Mulsant B et al (2016) Self-reported obstructive sleep apnea is associated with nonresponse to antidepressant pharmacotherapy in late-life depression. Depress Anxiety 33(12):1107–111310.1002/da.22555 PMC5156576 27636232
10.Chesson AL JrBerry RB Pack A Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults Sleep 2003 26 7 907 913 14655928 10.1093/sleep/26.7.907 Chesson AL Jr., Berry RB, Pack A (2003) Practice parameters for the use of portable monitoring devices in the investigation of suspected obstructive sleep apnea in adults. Sleep 26(7):907–91310.1093/sleep/26.7.907 14655928
11.Collop NA Anderson WM Boehlecke B Claman D Goldberg R Gottlieb DJ Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine J Clin Sleep Med 2007 3 7 737 747 10.5664/jcsm.27032 18198809 Collop NA, Anderson WM, Boehlecke B, Claman D, Goldberg R, Gottlieb DJ et al (2007) Clinical guidelines for the use of unattended portable monitors in the diagnosis of obstructive sleep apnea in adult patients. Portable Monitoring Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med 3(7):737–747PMC2556918 18198809
12.Riha RL Celmina M Cooper B Hamutcu-Ersu R Kaditis A Morley A ERS technical standards for using type III devices (limited channel studies) in the diagnosis of sleep disordered breathing in adults and children Eur Respir J 2023 61 1 2200422 10.1183/13993003.00422-2022 36609518 RihaRL, Celmina M, Cooper B, Hamutcu-Ersu R, Kaditis A, Morley A et al (2023) ERS technical standards for using type III devices (limited channel studies) in the diagnosis of sleep disordered breathing in adults and children. Eur Respir J 61(1):2200422. 10.1183/13993003.00422-2022 36609518
13.Nagappa M Liao P Wong J Auckley D Ramachandran SK Memtsoudis S Validation of the STOP-Bang Questionnaire as a Screening Tool for Obstructive Sleep Apnea among Different Populations: A Systematic Review and Meta-Analysis PLoS ONE 2015 10 12 e0143697 26658438 10.1371/journal.pone.0143697 Nagappa M, Liao P, Wong J, Auckley D, Ramachandran SK, Memtsoudis S et al (2015) Validation of the STOP-Bang Questionnaire as a Screening Tool for Obstructive Sleep Apnea among Different Populations: A Systematic Review and Meta-Analysis. PLoS ONE 10(12):e014369710.1371/journal.pone.0143697 PMC4678295 26658438
14.Chung F Yegneswaran B Liao P Chung SA Vairavanathan S Islam S STOP questionnaire: a tool to screen patients for obstructive sleep apnea Anesthesiology 2008 108 5 812 821 18431116 10.1097/ALN.0b013e31816d83e4 Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S et al (2008) STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology 108(5):812–82110.1097/ALN.0b013e31816d83e4 18431116
15.Chung F Abdullah HR Liao P STOP-Bang Questionnaire A Practical Approach to Screen for Obstructive Sleep Apnea Chest 2016 149 3 631 638 26378880 10.1378/chest.15-0903 Chung F, Abdullah HR, Liao P (2016) STOP-Bang Questionnaire: A Practical Approach to Screen for Obstructive Sleep Apnea. Chest 149(3):631–63810.1378/chest.15-0903 26378880
16.Gabryelska A Mokros Ł Kardas G Panek M Riha R Białasiewicz P The predictive value of BOAH scale for screening obstructive sleep apnea in patients at a sleep clinic in Scotland Sleep Breath 2021 25 1 355 359 10.1007/s11325-020-02114-0 32524336 PMC7987701 Gabryelska A, Mokros Ł, Kardas G, Panek M, Riha R, Białasiewicz P (2021) The predictive value of BOAH scale for screening obstructive sleep apnea in patients at a sleep clinic in Scotland. Sleep Breath 25(1):355–35910.1007/s11325-020-02114-0 PMC7987701 32524336
17.Xing Y Zhang Z Yin J Liu Y Shuai Z Liu Z Utilization of the GOAL questionnaire as a standardized screening tool for obstructive sleep apnea Sci Rep 2023 13 1 5489 10.1038/s41598-023-31247-x 37015938 Xing Y, Zhang Z, Yin J, Liu Y, Shuai Z, Liu Z et al (2023) Utilization of the GOAL questionnaire as a standardized screening tool for obstructive sleep apnea. Sci Rep 13(1):548910.1038/s41598-023-31247-x PMC10073216 37015938
18.Duarte RL Magalhães-da-Silveira FJ Oliveira ESTS Silva JA Mello FC Gozal D Obstructive Sleep Apnea Screening with a 4-Item Instrument, Named GOAL Questionnaire: Development, Validation and Comparative Study with No-Apnea, STOP-Bang, and NoSAS Nat Sci Sleep 2020 12 57 67 32158294 10.2147/NSS.S238255 Duarte RL, Magalhães-da-Silveira FJ, Oliveira ESTS, Silva JA, Mello FC, Gozal D (2020) Obstructive Sleep Apnea Screening with a 4-Item Instrument, Named GOAL Questionnaire: Development, Validation and Comparative Study with No-Apnea, STOP-Bang, and NoSAS. Nat Sci Sleep 12:57–6710.2147/NSS.S238255 PMC6986247 32158294
19.Marti-Soler H Hirotsu C Marques-Vidal P Vollenweider P Waeber G Preisig M The NoSAS score for screening of sleep-disordered breathing: a derivation and validation study Lancet Respiratory Med 2016 4 9 742 748 10.1016/S2213-2600(16)30075-3 27321086 Marti-Soler H, Hirotsu C, Marques-Vidal P, Vollenweider P, Waeber G, Preisig M et al (2016) The NoSAS score for screening of sleep-disordered breathing: a derivation and validation study. Lancet Resp Med 4(9):742–74810.1016/S2213-2600(16)30075-3 27321086
20.Duarte RLM Rabahi MF Magalhães-da-Silveira FJ de Oliveira ESTS Mello FCQ Gozal D Simplifying the Screening of Obstructive Sleep Apnea With a 2-Item Model, No-Apnea: A Cross-Sectional Study J Clin Sleep Med 2018 14 7 1097 1107 10.5664/jcsm.7202 29991419 Duarte RLM, Rabahi MF, Magalhães-da-Silveira FJ, de Oliveira ESTS, Mello FCQ, Gozal D (2018) Simplifying the Screening of Obstructive Sleep Apnea With a 2-Item Model, No-Apnea: A Cross-Sectional Study. J Clin Sleep Med 14(7):1097–110710.5664/jcsm.7202 PMC6040787 29991419
21.Lévy P Kohler M McNicholas WT Barbé F McEvoy RD Somers VK Obstructive sleep apnoea syndrome Nat Rev Dis Primers 2015 1 15015 27188535 10.1038/nrdp.2015.15 Lévy P, Kohler M, McNicholas WT, Barbé F, McEvoy RD, Somers VK et al (2015) Obstructive sleep apnoea syndrome. Nat Rev Dis Primers 1:1501510.1038/nrdp.2015.15 27188535
22.Krakow B Melendrez D Ferreira E Clark J Warner TD Sisley B Prevalence of insomnia symptoms in patients with sleep-disordered breathing Chest 2001 120 6 1923 1929 11742923 10.1378/chest.120.6.1923 Krakow B, Melendrez D, Ferreira E, Clark J, Warner TD, Sisley B et al (2001) Prevalence of insomnia symptoms in patients with sleep-disordered breathing. Chest 120(6):1923–192910.1378/chest.120.6.1923 11742923
23.Vanek J Prasko J Genzor S Ociskova M Kantor K Holubova M Obstructive sleep apnea, depression and cognitive impairment Sleep Med 2020 72 50 58 32544796 10.1016/j.sleep.2020.03.017 Vanek J, Prasko J, Genzor S, Ociskova M, Kantor K, Holubova M et al (2020) Obstructive sleep apnea, depression and cognitive impairment. Sleep Med 72:50–5810.1016/j.sleep.2020.03.017 32544796
24.Lyons R Barbir LA Owens R Colvonen PJ STOP-BANG screener vs objective obstructive sleep apnea testing among younger veterans with PTSD and insomnia: STOP-BANG does not sufficiently detect risk J Clin Sleep Med 2022 18 1 67 73 10.5664/jcsm.9498 34216197 Lyons R, Barbir LA, Owens R, Colvonen PJ (2022) STOP-BANG screener vs objective obstructive sleep apnea testing among younger veterans with PTSD and insomnia: STOP-BANG does not sufficiently detect risk. J Clin Sleep Med 18(1):67–7310.5664/jcsm.9498 PMC8807890 34216197
25.Bailer M Sprügel MI Stein EM Utz J Mestermann S Spitzer P Diagnostic accuracy of screening questionnaires for obstructive sleep apnea in psychiatric patients J Psychiatr Res 2025 186 280 288 40273811 10.1016/j.jpsychires.2025.04.026 Bailer M, Sprügel MI, Stein EM, Utz J, Mestermann S, Spitzer P et al (2025) Diagnostic accuracy of screening questionnaires for obstructive sleep apnea in psychiatric patients. J Psychiatr Res 186:280–28810.1016/j.jpsychires.2025.04.026 40273811
26.American Academy of Sleep MedicineInternational Classification of Sleep Disorders 2023 3Darien, ILAmerican Academy of Sleep MedicineAmerican Academy of Sleep Medicine (2023) nternational Classification of Sleep Disorders, 3rd edn, text revision (ICSD-3-TR). American Academy of Sleep Medicine, Darien, ILInternational Classification of Sleep Disorders, 3rd text revision (ICSD--TR) ed. edn. American Academy of Sleep Medicine, Darien, IL
27.Zeineddine S Chowdhuri S Apnea in Elderly Curr Sleep Med Rep 2019 5 1 13 22 10.1007/s40675-019-0134-y Zeineddine S, Chowdhuri S (2019) Apnea in Elderly. Curr Sleep Med Rep 5(1):13–22
28.Young T Peppard PE Gottlieb DJ Epidemiology of obstructive sleep apnea: a population health perspective Am J Respir Crit Care Med 2002 165 9 1217 1239 11991871 10.1164/rccm.2109080 Young T, Peppard PE, Gottlieb DJ (2002) Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 165(9):1217–123910.1164/rccm.2109080 11991871
29.Testelmans D Spruit MA Vrijsen B Sastry M Belge C Kalkanis A Comorbidity clusters in patients with moderate-to-severe OSA Sleep Breath 2022 26 1 195 204 10.1007/s11325-021-02390-4 33942208 Testelmans D, Spruit MA, Vrijsen B, Sastry M, Belge C, Kalkanis A et al (2022) Comorbidity clusters in patients with moderate-to-severe OSA. Sleep Breath 26(1):195–20410.1007/s11325-021-02390-4 33942208
30.Gleeson M McNicholas WT Bidirectional relationships of comorbidity with obstructive sleep apnoea Eur Respiratory Rev 2022 31 164 210256 10.1183/16000617.0256-2021 PMC9488957 35508332 Gleeson M, McNicholas WT (2022) Bidirectional relationships of comorbidity with obstructive sleep apnoea. Eur Respiratory Rev 31(164):21025610.1183/16000617.0256-2021 PMC9488957 35508332
31.Alzheimer’s disease facts and figuresAlzheimers Dement 2023 19 4 1598 1695 10.1002/alz.13016 36918389 Alzheimer’s Association (2023)Alzheimer’s disease facts and figures (2023) Alzheimers Dement 19(4):1598–169510.1002/alz.13016 36918389
32.Khurshid S Ashburner JM Ellinor PT McManus DD Atlas SJ Singer DE Prevalence and Incidence of Atrial Fibrillation Among Older Primary Care Patients JAMA Netw Open 2023 6 2 e2255838 e 36780164 10.1001/jamanetworkopen.2022.55838 Khurshid S, Ashburner JM, Ellinor PT, McManus DD, Atlas SJ, Singer DE et al (2023) Prevalence and Incidence of Atrial Fibrillation Among Older Primary Care Patients. JAMA Netw Open 6(2):e225583810.1001/jamanetworkopen.2022.55838 PMC11015386 36780164
33.Yousufuddin M Young N Aging and ischemic stroke Aging 2019 11 9 2542 2544 31043575 10.18632/aging.101931 Yousufuddin M, Young N (2019) Aging and ischemic stroke. Aging 11(9):2542–254410.18632/aging.101931 PMC6535078 31043575
34.Feltner C Wallace IF Aymes S Cook Middleton J Hicks KL Schwimmer M Screening for Obstructive Sleep Apnea in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force JAMA 2022 328 19 1951 1971 36378203 10.1001/jama.2022.18357 Feltner C, Wallace IF, Aymes S, Cook Middleton J, Hicks KL, Schwimmer M et al (2022) Screening for Obstructive Sleep Apnea in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 328(19):1951–197110.1001/jama.2022.18357 36378203
35.Martins EF Martinez D Cortes AL Nascimento N Brendler J Exploring the STOP-BANG questionnaire for obstructive sleep apnea screening in seniors J Clin Sleep Med 2020 16 2 199 206 10.5664/jcsm.8166 31992408 Martins EF, Martinez D, Cortes AL, Nascimento N, Brendler J (2020) Exploring the STOP-BANG questionnaire for obstructive sleep apnea screening in seniors. J Clin Sleep Med 16(2):199–20610.5664/jcsm.8166 PMC7053028 31992408
36.Bailer M Stein EM Sprügel MI Mestermann S Spitzer P Utz J Portable polygraphic device (Somnocheck micro CARDIO®) provides accurate diagnostic information in psychiatric patients at risk for obstructive sleep apnoea: an observational cohort study BMC Psychiatry 2024 24 1 607 10.1186/s12888-024-06049-8 39256715 Bailer M, Stein EM, Sprügel MI, Mestermann S, Spitzer P, Utz J et al (2024) Portable polygraphic device (Somnocheck micro CARDIO®) provides accurate diagnostic information in psychiatric patients at risk for obstructive sleep apnoea: an observational cohort study. BMC Psychiatry 24(1):60710.1186/s12888-024-06049-8 PMC11389046 39256715
37.World Health OrganizationICD-10: international statistical classification of diseases and related health problems : tenth revision 2004 2ed. GenevaWorld Health OrganizationWorld Health Organization (2004) ICD-10: international statistical classification of diseases and related health problems : tenth revision, 2nd edn. World Health Organization, Geneva
38.Deutsche Gesellschaft für Geriatrie e. VS3-Leitlinie „Umfassendes Geriatrisches Assessment (Comprehensive Geriatric Assessment, CGA) bei hospitalisierten Patientinnen und Patienten. Langversion 1.1. AWMF 2024 Report No084 – 003Deutsche Gesellschaft für Geriatrie e. V (2024) S3-Leitlinie „Umfassendes Geriatrisches Assessment (Comprehensive Geriatric Assessment, CGA) bei hospitalisierten Patientinnen und Patienten." Langversion 1.1. AWMF. 084 – 003,
39.Kapur VK Auckley DH Chowdhuri S Kuhlmann DC Mehra R Ramar K Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline J Clin Sleep Med 2017 13 3 479 504 10.5664/jcsm.6506 28162150 Kapur VK, Auckley DH, Chowdhuri S, Kuhlmann DC, Mehra R, Ramar K et al (2017) Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 13(3):479–50410.5664/jcsm.6506 PMC5337595 28162150
40.Sommermeyer D Zou D Grote L Hedner J Detection of sleep disordered breathing and its central/obstructive character using nasal cannula and finger pulse oximeter J Clin Sleep Med 2012 8 5 527 533 10.5664/jcsm.2148 23066364 Sommermeyer D, Zou D, Grote L, Hedner J (2012) Detection of sleep disordered breathing and its central/obstructive character using nasal cannula and finger pulse oximeter. J Clin Sleep Med 8(5):527–53310.5664/jcsm.2148 PMC3459198 23066364
41.Gomes T Benedetti A Lafontaine AL Kimoff RJ Robinson A Kaminska M Validation of STOP, STOP-BANG, STOP-BAG, STOP-B28, and GOAL screening tools for identification of obstructive sleep apnea in patients with Parkinson disease J Clin Sleep Med 2023 19 1 45 54 10.5664/jcsm.10262 36004740 Gomes T, Benedetti A, Lafontaine AL, Kimoff RJ, Robinson A, Kaminska M (2023) Validation of STOP, STOP-BANG, STOP-BAG, STOP-B28, and GOAL screening tools for identification of obstructive sleep apnea in patients with Parkinson disease. J Clin Sleep Med 19(1):45–5410.5664/jcsm.10262 PMC9806789 36004740
42.Menezes-Júnior LAAd, Fajardo VC Neto RMN SNd F FLPd O Pimenta FAP The predictive values of BOAH and No-apnea score for screening obstructive sleep apnea in rotating shift worker drivers Sleep Medicine: X 2023 6 100084 10.1016/j.sleepx.2023.100084 PMC10497842 37711594 de Menezes-Júnior LAA, Fajardo VC, do Nascimento Neto RM, de Freitas SN, de Oliveira FLP, Pimenta FAP et al (2023) The predictive values of BOAH and No-apnea score for screening obstructive sleep apnea in rotating shift worker drivers. Sleep Medicine: X 6:10008410.1016/j.sleepx.2023.100084 PMC10497842 37711594
43.von Elm E Altman DG Egger M Pocock SJ Gøtzsche PC Vandenbroucke JP Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies BMJ 2007 335 7624 806 808 10.1136/bmj.39335.541782.AD PMC2034723 17947786 von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP (2007) Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ 335(7624):806–80810.1136/bmj.39335.541782.AD PMC2034723 17947786
44.Young T Shahar E Nieto FJ Redline S Newman AB Gottlieb DJ Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study Arch Intern Med 2002 162 8 893 900 11966340 10.1001/archinte.162.8.893 Young T, Shahar E, Nieto FJ, Redline S, Newman AB, Gottlieb DJ et al (2002) Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 162(8):893–90010.1001/archinte.162.8.893 11966340
45.Ancoli-Israel S Kripke DF Klauber MR Mason WJ Fell R Kaplan O Sleep-disordered breathing in community-dwelling elderly Sleep 1991 14 6 486 495 1798880 10.1093/sleep/14.6.486 Ancoli-Israel S, Kripke DF, Klauber MR, Mason WJ, Fell R, Kaplan O (1991) Sleep-disordered breathing in community-dwelling elderly. Sleep 14(6):486–49510.1093/sleep/14.6.486 PMC2756990 1798880
46.Punjabi NM The epidemiology of adult obstructive sleep apnea Proc Am Thorac Soc 2008 5 2 136 143 18250205 10.1513/pats.200709-155MG Punjabi NM (2008) The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 5(2):136–14310.1513/pats.200709-155MG PMC2645248 18250205
47.Guichard K Marti-Soler H Micoulaud-Franchi J-A Philip P Marques-Vidal P Vollenweider P The NoSAS score: A new and simple screening tool for obstructive sleep apnea syndrome in depressive disorder J Affect Disord 2018 227 136 140 29055261 10.1016/j.jad.2017.10.015 Guichard K, Marti-Soler H, Micoulaud-Franchi J-A, Philip P, Marques-Vidal P, Vollenweider P et al (2018) The NoSAS score: A new and simple screening tool for obstructive sleep apnea syndrome in depressive disorder. J Affect Disord 227:136–14010.1016/j.jad.2017.10.015 29055261
48.Silva DVE Alves D Nóbrega M Ribeiro F Franco LYY Silva IRD Obstructive sleep apnea screening in different age groups: performance of the Berlin, STOP-Bang questionnaires and Epworth Sleepiness Scale Braz J Otorhinolaryngol 2023 89 4 101283 37418853 10.1016/j.bjorl.2023.101283 Silva DVE, Alves D, Nóbrega M, Ribeiro F, Franco LYY, Silva IRD et al (2023) Obstructive sleep apnea screening in different age groups: performance of the Berlin, STOP-Bang questionnaires and Epworth Sleepiness Scale. Braz J Otorhinolaryngol 89(4):10128310.1016/j.bjorl.2023.101283 PMC10345254 37418853
49.Godoy PH Nucera A Colcher AP de Andrade JE Alves D Screening for obstructive sleep apnea in elderly: performance of the Berlin and STOP-Bang questionnaires and the Epworth sleepiness scale using polysomnography as gold standard Sleep Sci 2022 15 2 136 142 35755908 10.5935/1984-0063.20220033 Godoy PH, Nucera A, Colcher AP, de Andrade JE, Alves D (2022) Screening for obstructive sleep apnea in elderly: performance of the Berlin and STOP-Bang questionnaires and the Epworth sleepiness scale using polysomnography as gold standard. Sleep Sci 15(2):136–14210.5935/1984-0063.20220033 PMC9210560 35755908
50.Jehan S Auguste E Pandi-Perumal SR Kalinowski J Myers AK Zizi F Depression, obstructive sleep apnea and psychosocial health Sleep Med Disord 2017 1 3 58 63 10.15406/smdij.2017.01.00012 PMC5836734 29517078 JehanS, Auguste E, Pandi-Perumal SR, Kalinowski J, Myers AK, Zizi F et al (2017) Depression, obstructive sleep apnea and psychosocial health. Sleep Med Disord 1(3):58–63. 10.15406/smdij.2017.01.00012 PMC5836734 29517078
51.Day GS Long A Morris JC Assessing the Reliability of Reported Medical History in Older Adults J Alzheimers Dis 2020 78 2 643 652 33016919 10.3233/JAD-200842 Day GS, Long A, Morris JC (2020) Assessing the Reliability of Reported Medical History in Older Adults. J Alzheimers Dis 78(2):643–65210.3233/JAD-200842 PMC7669691 33016919
52.Kolanowski A Gilmore-Bykovskyi A Hill N Massimo L Mogle J Measurement Challenges in Research With Individuals With Cognitive Impairment Res Gerontol Nurs 2019 12 1 7 15 30653646 10.3928/19404921-20181212-06 Kolanowski A, Gilmore-Bykovskyi A, Hill N, Massimo L, Mogle J (2019) Measurement Challenges in Research With Individuals With Cognitive Impairment. Res Gerontol Nurs 12(1):7–1510.3928/19404921-20181212-06 PMC6500490 30653646
53.MasonM, Cates CJ, Smith I (2015) Effects of opioid, hypnotic and sedating medications on sleep-disordered breathing in adults with obstructive sleep apnoea. Cochrane Database Syst Rev 7 CD011090. 10.1002/14651858.CD011090.pub2 26171909
54.Shirani A Paradiso S Dyken ME The impact of atypical antipsychotic use on obstructive sleep apnea: a pilot study and literature review Sleep Med 2011 12 6 591 597 21645873 10.1016/j.sleep.2010.12.013 Shirani A, Paradiso S, Dyken ME (2011) The impact of atypical antipsychotic use on obstructive sleep apnea: a pilot study and literature review. Sleep Med 12(6):591–59710.1016/j.sleep.2010.12.013 PMC3789524 21645873
55.Nutt D Wilson S Paterson L Sleep disorders as core symptoms of depression Dialogues Clin Neurosci 2008 10 3 329 336 18979946 10.31887/DCNS.2008.10.3/dnutt Nutt D, Wilson S, Paterson L (2008) Sleep disorders as core symptoms of depression. Dialogues Clin Neurosci 10(3):329–33610.31887/DCNS.2008.10.3/dnutt PMC3181883 18979946
56.Patil SP Ayappa IA Caples SM Kimoff RJ Patel SR Harrod CG Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline J Clin Sleep Med 2019 15 2 335 343 10.5664/jcsm.7640 30736887 Patil SP, Ayappa IA, Caples SM, Kimoff RJ, Patel SR, Harrod CG (2019) Treatment of Adult Obstructive Sleep Apnea with Positive Airway Pressure: An American Academy of Sleep Medicine Clinical Practice Guideline. J Clin Sleep Med 15(2):335–34310.5664/jcsm.7640 PMC6374094 30736887
57.Stuck BA Arzt M Fietze I Galetke W Hein H Heiser C Teil-Aktualisierung S3-Leitlinie Schlafbezogene Atmungsstörungen bei Erwachsenen Somnologie 2020 24 3 176 208 10.1007/s11818-020-00257-6 Stuck BA, Arzt M, Fietze I, Galetke W, Hein H, Heiser C et al (2020) Teil-Aktualisierung S3-Leitlinie Schlafbezogene Atmungsstörungen bei Erwachsenen. Somnologie 24(3):176–208
58.Antonaglia C Fabozzi A Steffanina A Ture R Palange P Confalonieri M Walking the fine line between OSA and aging Sleep Breath 2025 29 3 195 10.1007/s11325-025-03343-x 40407983 Antonaglia C, Fabozzi A, Steffanina A, Ture R, Palange P, Confalonieri M (2025) Walking the fine line between OSA and aging. Sleep Breath 29(3):19510.1007/s11325-025-03343-x PMC12101997 40407983
59.Bixler EO Vgontzas AN Lin HM Ten Have T Rein J Vela-Bueno A Prevalence of sleep-disordered breathing in women: effects of gender Am J Respir Crit Care Med 2001 163 3 Pt 1 608 613 11254512 10.1164/ajrccm.163.3.9911064 Bixler EO, Vgontzas AN, Lin HM, Ten Have T, Rein J, Vela-Bueno A et al (2001) Prevalence of sleep-disordered breathing in women: effects of gender. Am J Respir Crit Care Med 163(3 Pt 1):608–61310.1164/ajrccm.163.3.9911064 11254512
60.Young T Finn L Peppard PE Szklo-Coxe M Austin D Nieto FJ Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort Sleep 2008 31 8 1071 1078 18714778 Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ et al (2008) Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin sleep cohort. Sleep 31(8):1071–1078PMC2542952 18714778
61.Ghavami T Kazeminia M Ahmadi N Rajati F Global Prevalence of Obstructive Sleep Apnea in the Elderly and Related Factors: A Systematic Review and Meta-Analysis Study J Perianesth Nurs 2023 38 6 865 875 37318436 10.1016/j.jopan.2023.01.018 Ghavami T, Kazeminia M, Ahmadi N, Rajati F (2023) Global Prevalence of Obstructive Sleep Apnea in the Elderly and Related Factors: A Systematic Review and Meta-Analysis Study. J Perianesth Nurs 38(6):865–87510.1016/j.jopan.2023.01.018 37318436
62.Leppänen T Töyräs J Mervaala E Penzel T Kulkas A Severity of individual obstruction events increases with age in patients with obstructive sleep apnea Sleep Med 2017 37 32 37 28899537 10.1016/j.sleep.2017.06.004 Leppänen T, Töyräs J, Mervaala E, Penzel T, Kulkas A (2017) Severity of individual obstruction events increases with age in patients with obstructive sleep apnea. Sleep Med 37:32–3710.1016/j.sleep.2017.06.004 28899537
63.OsorioRS, Martínez-García M, Rapoport DM (2022) Sleep apnoea in the elderly: a great challenge for the future. Eur Respir J 4 2101649. 10.1183/13993003.01649-2021 PMC8942873 34561285
Come citare questo studio
Bailer M, Stein EM, Sprügel MI, Mestermann S, Sonnauer F, Schwarz JA, Utz J, Spitzer P, Kornhuber J. (2026). Reduced diagnostic accuracy of screening questionnaires in older psychiatric patients at risk for obstructive sleep apnea: an observational cohort study.. Sleep & breathing = Schlaf & Atmung. DOI: 10.1007/s11325-026-03847-0
Consulta la pubblicazione originale ↗